In support of local health, wellness and educational programs, the Parkinson’s Foundation is granting $1.5 million to Parkinson’s community…
Mary Chapman
Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Mary Chapman
The non-profit Parkinson’s Foundation will host its annual fundraiser, the New York Gala, on May 7, with a…
Acadia Pharmaceuticals is marking Parkinson’s Awareness Month by supporting a host of events and activities in April throughout…
In partnership with the Edmond J. Safra Foundation, The Michael J. Fox Foundation (MJFF) for Parkinson’s Research has…
Young-onset Patients, Like This 34-Year-Old Mom, Focus of Parkinson’s Foundation and Awareness Month
Christina Korines was 22 — a recent college graduate and a newly minted Spanish teacher — when she noticed a…
With the goal of advancing Parkinson’s disease (PD) diagnosis and therapy by securely and safely sharing patient-produced data, the healthcare…
As it sometimes happens in rare-disease research, a prospective therapy for one disorder has potential to help another. So it…
To further support its quest to advance a new therapy for Parkinson’s disease and related disorders, Inhibikase Therapeutics has…
The National Institutes of Health (NIH) has granted a Michigan State University scientist $5 million to study a possible…
Some 10 percent of Parkinson’s patients carry a mutation in the GBA gene, making it the most common genetic…